文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

COVID-19患者院内心搏骤停后心肺复苏结局可能受骤停病因和当地疫情状况影响

In COVID-19 Patients Who Suffer In-Hospital Cardiac Arrest, Cardiopulmonary Resuscitation Outcomes May Be Impacted by Arrest Etiology and Local Pandemic Conditions.
PubMed 文献 · Crit Care Explor · 2022-02-08
一句话结论COVID-19院内心搏骤停后心肺复苏存活率低,骤停前有急性呼吸事件者30天存活可能性更高,作者提示该类亚群高级心血管生命支持可能更成功。

该回顾性队列研究纳入纽约一家医院2020年春季103例和2021年春季26例COVID-19院内心搏骤停后接受复苏的患者。2020年队列34.0%恢复自主循环至少20分钟,14.6%存活至骤停后30天;2021年队列分别为57.7%和11.5%。2020年队列中30天存活者骤停发生更晚(第22天 vs 第7天,p=0.008)且骤停前有急性呼吸事件比例更高(93.3% vs 27.3%,p<0.001);2021年队列中30天存活者更年轻(46.3 vs 67.8,p=0.03)。作者认为恢复自主循环率可能受医院负荷影响,骤停前有急性呼吸事件者30天存活可能性更高。

要点

  • 2020年春季103例COVID-19院内心搏骤停复苏患者中,35例(34.0%)恢复自主循环至少20分钟,15例(14.6%)存活至骤停后30天。
  • 2021年春季26例中,15例(57.7%)恢复自主循环至少20分钟,3例(11.5%)存活至30天,2例(7.7%)存活至出院。
  • 2020年队列30天存活者骤停发生更晚(第22天 vs 第7天,p=0.008),骤停前有急性呼吸事件比例更高(93.3% vs 27.3%,p<0.001)。
  • 2021年队列30天存活者更年轻(46.3 vs 67.8,p=0.03),其余组间无显著差异。
  • 作者认为恢复自主循环率可能受医院负荷影响,骤停前有急性呼吸事件者高级心血管生命支持可能更成功。

适用人群与场景

  • 2020年3月1日至5月31日及2021年3月1日至5月31日因COVID-19入院、院内心搏骤停后接受复苏的患者。
  • 地点为纽约New York-Presbyterian Hospital/Columbia University Irving Medical Center。

研究设计与关键结果

  • 回顾性队列研究:2020年春季103例COVID-19院内心搏骤停复苏患者中,35例(34.0%)恢复自主循环至少20分钟,15例(14.6%)存活至骤停后30天。
  • 2020年队列30天存活者与未存活者比较:骤停发生更晚(第22天 vs 第7天;p=0.008),骤停前有急性呼吸事件比例更高(93.3% vs 27.3%;p<0.001)。
  • 2020年队列30天存活者中11例(73.3%)存活至出院,其中8例(72.7%)脑功能分类评分为1或2。
  • 2021年春季26例COVID-19院内心搏骤停复苏患者中,15例(57.7%)恢复自主循环至少20分钟,3例(11.5%)存活至骤停后30天,2例(7.7%)存活至出院,二者脑功能分类评分均≤2。
  • 2021年队列30天存活者更年轻(46.3 vs 67.8;p=0.03),其余组间无显著差异。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,COVID-19院内心搏骤停复苏后恢复自主循环率可能受医院负荷影响。
  • 作者认为,骤停前有急性呼吸事件的患者30天存活可能性更高,提示该亚群高级心血管生命支持可能更成功。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The utility and risks to providers of performing cardiopulmonary resuscitation after in-hospital cardiac arrest in COVID-19 patients have been questioned. Additionally, there are discrepancies in reported COVID-19 in-hospital cardiac arrest survival rates. We describe outcomes after cardiopulmonary resuscitation for in-hospital cardiac arrest in two COVID-19 patient cohorts.

DESIGN: Retrospective cohort study.

SETTING: New York-Presbyterian Hospital/Columbia University Irving Medical Center in New York, NY.

PATIENTS: Those admitted with COVID-19 between March 1, 2020, and May 31, 2020, as well as between March 1, 2021, and May 31, 2021, who received resuscitation after in-hospital cardiac arrest.

INTERVENTIONS: None.

MEASUREMENT AND MAIN RESULTS: Among 103 patients with coronavirus disease 2019 who were resuscitated after in-hospital cardiac arrest in spring 2020, most self-identified as Hispanic/Latino or African American, 35 (34.0%) had return of spontaneous circulation for at least 20 minutes, and 15 (14.6%) survived to 30 days post-arrest. Compared with nonsurvivors, 30-day survivors experienced in-hospital cardiac arrest later (day 22 vs day 7; p = 0.008) and were more likely to have had an acute respiratory event preceding in-hospital cardiac arrest (93.3% vs 27.3%; p < 0.001). Among 30-day survivors, 11 (73.3%) survived to hospital discharge, at which point 8 (72.7%) had Cerebral Performance Category scores of 1 or 2. Among 26 COVID-19 patients resuscitated after in-hospital cardiac arrest in spring 2021, 15 (57.7%) had return of spontaneous circulation for at least 20 minutes, 3 (11.5%) survived to 30 days post in-hospital cardiac arrest, and 2 (7.7%) survived to hospital discharge, both with Cerebral Performance Category scores of 2 or less. Those who survived to 30 days post in-hospital cardiac arrest were younger (46.3 vs 67.8; p = 0.03), but otherwise there were no significant differences between groups.

CONCLUSIONS: Patients with COVID-19 who received cardiopulmonary resuscitation after in-hospital cardiac arrest had low survival rates. Our findings additionally show return of spontaneous circulation rates in these patients may be impacted by hospital strain and that patients with in-hospital cardiac arrest preceded by acute respiratory events might be more likely to survive to 30 days, suggesting Advanced Cardiac Life Support efforts may be more successful in this subpopulation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Murphy CG, Nishikawa MS, Char ST, et al. In COVID-19 Patients Who Suffer In-Hospital Cardiac Arrest, Cardiopulmonary Resuscitation Outcomes May Be Impacted by Arrest Etiology and Local Pandemic Conditions. Crit Care Explor. 2022. PMID: 35156046. doi:10.1097/CCE.0000000000000605

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。